References in periodicals archive ?
Caveat against the use of activated recombinant factor VII for intractable bleeding in cardiac surgery.
Two common functional polymorphisms in the promoter region of the coagulation factor VII gene determining plasma factor VII activity and mass concentration.
Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force.
Expected results of laboratory tests for various inherited bleeding conditions Inherited bleeding condition INR/PT PTT [down arrow] Fibrinogen [up arrow] [up arrow] Dysfibrinogenaemia [up arrow] [up arrow] (bleeding disorder) [down arrow] Prothrombin [up arrow] [up arrow] [down arrow] Factor V [up arrow] [up arrow] [down arrow] Factor VII [up arrow] N [down arrow] Factor VIII N [up arrow] ([dagger]) [down arrow] Factor IX N [up arrow] ([dagger]) [down arrow] Factor X [up arrow] [up arrow] [down arrow] Factor XI N [up arrow] [down arrow] Factor XIII N N [down arrow] N N [[alpha].
Control of Bleeding Caused by Thrombocytopenia Associated With Hematologic Malignancy: An Audit of the Clinical Use of Recombinant Activated Factor VII.
Factor VII, also known as Stable Factor and Proconvertin, is a vitamin K-dependent glycoprotein that is produced in the liver.
Severe Bleeding required platelet transfusion and Recombinant Human- activated factor VII administration.
PAI-1, tPA, prothrombin and Factor VII were selected; the effects of the phytoestrogens on the remaining genes was within the background range (data not shown).
As for Factor VII, the results of the CONTROL trial showed efficacy and safety of recombinant activated Recombinant Factor VII in the management of refractory traumatic haemorrhage, however, even though it reduced blood product use but it did not affect mortality compared with placebo.
In concordance with our findings, many authors have stated that air pollutants can reduce PT and increase platelet levels, fibrin degradation products, and Factor VII levels.